THC Therapeutics, Inc. Annual Cost of Revenue in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
THC Therapeutics, Inc. quarterly/annual Cost of Revenue history and growth rate from 2019 to 2023.
  • THC Therapeutics, Inc. Cost of Revenue for the quarter ending April 30, 2024 was $0.000.
  • THC Therapeutics, Inc. Cost of Revenue for the twelve months ending April 30, 2024 was $0.000.
  • THC Therapeutics, Inc. annual Cost of Revenue for 2023 was $0.000.
  • THC Therapeutics, Inc. annual Cost of Revenue for 2022 was $0.000.
  • THC Therapeutics, Inc. annual Cost of Revenue for 2021 was $0.000.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Aug 1, 2022 Jul 31, 2023 10-K 2024-02-26
2022 $0 $0 Aug 1, 2021 Jul 31, 2022 10-K 2024-02-26
2021 $0 $0 Aug 1, 2020 Jul 31, 2021 10-K 2022-11-25
2020 $0 $0 Aug 1, 2019 Jul 31, 2020 10-K 2022-03-31
2019 $0 Aug 1, 2018 Jul 31, 2019 10-K 2020-11-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.